Pelthos Therapeutics Inc.

PTHS | AMEX

Price Alert Chart Builder DCF Calculator

$23.15

+$0.50 (+2.21%)

At close: Sep 21, 2026, 4:00 PM ET

$23.15

$0 (0.00%)

After-hours: Sep 21, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.21%

(1D)

Rating

Updated: Aug 13, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $80.46M

1D Range

22.46 23.70

52W Range

18.19 37.50

Valuation (TTM)

PE -0.55

PB -53.61

EV/EBITDA -2.05

Valuation (NTM)

Forward PE 18.56

Forward PEG 0.01

Price Target $54.50

Cash Flow

FCF Yield -52.9%

SBC Adj. FCF Yield -52.9%

SBC Impact N/A

Margins

Gross Margin 54.7%

Operating Margin -133.4%

FCF Margin -98.4%

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | 142.6%

Dil EPS 3Y | 5Y -31.1% | -48.8%

FCF 3Y | 5Y -110.5% | N/A

Returns

ROA -52.1%

ROE -218.9%

ROIC -49.4%

Financial Health

Net Debt

$46M

Current Ratio 1.98

Interest Coverage -7.81

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primar...

Sector Healthcare

Industry Biotechnology

Employees 92

IPO Date Feb 15, 2024

Website pelthos.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$54.50

Upside

+135.42%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞